Breaks Categories: News

WednesdayMay 15, 2024 9:00 am

NetworkNewsBreaks – TC BioPharm (Holdings) PLC (NASDAQ: TCBP) Initiates Compassionate Use Program in the UK Expanding Access to TCB008

TC BioPharm (NASDAQ: TCBP), a clinical stage biotechnology company developing allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that TCB008, its lead therapeutic, will be available to patients through a newly launched compassionate use program in the U.K. The announcement noted that this program will provide medical practitioners with treatment options for patients who are ineligible to access experimental treatments through ongoing clinical studies and those whose clinical needs cannot currently be met with licensed treatments. “In addition to helping patients, this step will increase our data set and knowledge around TCB-008 and inform a broader…

Continue Reading

WednesdayMay 15, 2024 8:30 am

NetworkNewsBreaks – NanoViricides (NYSE American: NNVC) Releases Q2 Financial Report

NanoViricides (NYSE American: NNVC), a global leader in broad-spectrum antiviral nanomedicines, has filed on its second-quarter 2024 financial results for the period ending March 31, 2024; the company filed the report with the U.S. Securities and Exchange Commission on May 14, 2024. Notable numbers from the report include cash and cash equivalent totaling $3.51 million, with additional agreements adding approximately $2.5 million more in available cash with property, equipment and intangible assets reported at approximately $7.92 million. The report also noted that the company has a clinical asset in NV-387 that is available for partnering, which could result in a…

Continue Reading

TuesdayMay 14, 2024 4:44 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q3 Fiscal 2024 Financial Results, Business Update

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates, is reporting on its financial and business results for the third quarter of 2024, the period that ended March 31, 2024. Business highlights included the announcement of preclinical data supporting both the company’s INM-901 and INM-089 programs; the continued development of its ALZ program, with long-term behavioral and mechanism of action/receptor interaction studies underway; and the announcement of Dr. David G. Morgan, a leader in neurodegenerative disease, to the company’s scientific advisory board. The report also noted that BayMedica is operating…

Continue Reading

TuesdayMay 14, 2024 4:24 pm

NetworkNewsBreaks – GEMXX Corporation (GEMZ) Makes ‘Landmark Move,’ Enters Oil and Gas Exploration and Development Partnership

GEMXX (OTC: GEMZ), a leading provider of exquisite gemstone jewelry, has announced a partnership with Latin Energy Partners Inc. (“LEP”) that both companies are calling a “landmark move” in the pursuit of oil exploration and development. The strategic collaboration is designed to support the company’s expansion of its business mode. According to the announcement, the agreement outlines terms for the two companies to jointly drill four test wells in a promising geological formation in a Latin America country. The agreement is based on promising preliminary explorations in two target basins that have shown extensive sedimentary deposits conducive to successful oil…

Continue Reading

TuesdayMay 14, 2024 4:08 pm

NetworkNewsBreaks – Rejuvine Life Sciences Launches Crowdfunding Campaign

Rejuvine Life, dedicated to developing natural healthcare solutions, today announced a crowdfunding campaign to expand its U.S. product line and advance diabetes research management. According to the announcement, the company utilizes natural resources to support the millions worldwide living with diabetes. Skordo Plus, Rejuvine Life’s leading product, is a garlic-based supplement designed to help regulate blood sugar levels and enhance overall well-being. “We believe everyone deserves access to safe and effective healthcare solutions,” said Pat Theenathayalan, CEO of Rejuvine Life Sciences. “This crowdfunding campaign is a chance for individuals passionate about health to join us in making a significant impact…

Continue Reading

TuesdayMay 14, 2024 3:48 pm

NetworkNewsBreaks – Energy and Water Development Corp. (EAWD) Featured in The Harvest Podcast

Energy and Water Development Corp. (OTCQB: EAWD), a leading water and energy solutions provider, was featured in the latest episode of The Harvest Podcast, a series highlighting thought leaders, experts and breakthrough companies making disruptive and impactful contributions to society through groundbreaking initiatives. The company’s CEO Irma Velazquez, MSc joined the program to provide an introduction to EAWD and discuss its core values and mission. “Energy and Water Development Corp. is a leading engineering company focused on innovation relating to the generation of sustainable water and energy supply. Leveraging our intellectual property surrounding the configuration of our systems, we put…

Continue Reading

TuesdayMay 14, 2024 3:31 pm

NetworkNewsBreaks – Zoned Properties Inc. (ZDPY) Releases Q1 2024 Financial Results Showing 22% Revenue Growth

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, including legalized cannabis, released its financial results for Q1 2024, the period ended March 31; the company also noted recent business highlights. According to the report, financial highlights include revenues totaling $837,052 for the quarter ended March 31, 2024, compared to $688,024 million revenues for the same quarter 2023, representing an increase of 22%; net income of $96,473, or $0.01 per fully diluted share, as compared to a net loss of $309,648, or ($0.03) per fully diluted share, for the same quarter in 2023, representing…

Continue Reading

TuesdayMay 14, 2024 3:21 pm

NetworkNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Participation Schedule for Upcoming May Conferences

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, today announced that it will participate in three investor conferences in May. Clene will participate in one-on-one meetings at the Mizuho Neuroscience Summit 2024, the Benchmark 2024 Healthcare House Call Virtual Conference, and the Virtual A.G.P. Healthcare Conference. See the announcement for more information, including dates and locations of the events. To view the full press release, visit https://nnw.fm/J5EZp About Clene Inc. Clene (along with its…

Continue Reading

TuesdayMay 14, 2024 3:12 pm

NetworkNewsBreaks – Scorpius Holdings Inc. (NYSE American: SCPX) Announces Pricing of Underwritten Public Offering

Scorpius (NYSE American: SCPX), an integrated contract development and manufacturing organization (“CDMO”), has announced the pricing of its underwritten public offering of 60,000,000 common units and/or pre-funded units in lieu thereof. Each common (or pre-funded) unit is being offered at a public offering price of $0.10 (inclusive of the pre-funded warrant exercise price) and consists of one share of common stock (or pre-funded warrant to purchase one share of common stock in lieu thereof) and a common warrant to purchase one share of common stock. The common warrants will have an exercise price of $0.12 per share and will be…

Continue Reading

TuesdayMay 14, 2024 2:57 pm

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces $150 Million Financing Commitment Covering Commercial Sales Efforts, Capital Needs for Next 13 Months

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, has received a $100 million financing commitment from a family office; the company has also sold up to an additional $50 million of senior secured convertible notes to family offices and high net worth investors. According to the announcement, this $150 million capital infusion allows Mullen and Bollinger to operate and expand domestic and international commercial sales efforts as well as meet its capital needs over the next 13 months. This news comes on the heels of several advancements announced by the company, including California Air Resource Board (“CARB”) HVIP approval…

Continue Reading